Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27.65 HKD | 0.00% |
|
-2.30% | 0.00% |
06-17 | Qyuns Therapeutics Releases Data from Phase 2 Trial for Prurigo Nodularis Drug | MT |
05-30 | Qyuns Therapeutics Enrolls First Subject in Phase 3 Trial of Skin Disease Drug | MT |
- Stock Market
- Equities
- 2509 Stock
- News Qyuns Therapeutics Co., Ltd.
- Press Releases